Valproic acid Completed Phase 2 Trials for Retinitis Pigmentosa (RP) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01233609Trial of Oral Valproic Acid for Retinitis Pigmentosa